CN112544767A - Preparation method of selenium-rich tabletted candy - Google Patents
Preparation method of selenium-rich tabletted candy Download PDFInfo
- Publication number
- CN112544767A CN112544767A CN202011554331.1A CN202011554331A CN112544767A CN 112544767 A CN112544767 A CN 112544767A CN 202011554331 A CN202011554331 A CN 202011554331A CN 112544767 A CN112544767 A CN 112544767A
- Authority
- CN
- China
- Prior art keywords
- powder
- selenium
- tabletted
- tabletted candy
- raw materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229910052711 selenium Inorganic materials 0.000 title claims abstract description 44
- 239000011669 selenium Substances 0.000 title claims abstract description 44
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 title claims abstract description 43
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 30
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims abstract description 20
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 18
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 18
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 18
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 18
- 235000008434 ginseng Nutrition 0.000 claims abstract description 18
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 18
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 16
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 16
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 16
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 16
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 16
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 16
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 16
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 16
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 16
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 16
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 14
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 12
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 12
- 239000004480 active ingredient Substances 0.000 claims abstract description 9
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims description 24
- 241000208340 Araliaceae Species 0.000 claims description 17
- 241001092040 Crataegus Species 0.000 claims description 15
- 102000008114 Selenoproteins Human genes 0.000 claims description 8
- 108010074686 Selenoproteins Proteins 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 238000007873 sieving Methods 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 229940091258 selenium supplement Drugs 0.000 description 37
- 241000282414 Homo sapiens Species 0.000 description 11
- 230000000694 effects Effects 0.000 description 9
- 235000013305 food Nutrition 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 244000228451 Stevia rebaudiana Species 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003623 enhancer Substances 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 241000756042 Polygonatum Species 0.000 description 2
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 235000011477 liquorice Nutrition 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 230000004792 oxidative damage Effects 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 244000189799 Asimina triloba Species 0.000 description 1
- 235000006264 Asimina triloba Nutrition 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 244000188472 Ilex paraguariensis Species 0.000 description 1
- 235000003368 Ilex paraguariensis Nutrition 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 244000185386 Thladiantha grosvenorii Species 0.000 description 1
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000005880 cancer cell killing Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 239000003874 central nervous system depressant Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 230000007866 hepatic necrosis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 125000003748 selenium group Chemical group *[Se]* 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/42—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/44—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses a preparation method of a selenium-rich tabletted candy, wherein the active ingredients in the tabletted candy and the weight percentage of the active ingredients in the total tabletted candy are as follows: 7.5-8.4 wt% of selenium protein powder; 13-17 wt% of hawthorn; 13-17 wt% of maltodextrin; 7.42 to 8.21 weight percent of stevia powder; 7.31-8.05 wt% of ginseng powder; 1.13-7.05 wt% of magnesium stearate. The invention aims to provide a preparation method of a selenium-rich tabletted candy, and simultaneously discloses a preparation method of the tabletted candy.
Description
Technical Field
The invention belongs to the field of health care products, and particularly relates to a preparation method of a selenium-rich tabletted candy.
Background
Chinese patent CN 201310031753.4 discloses a polygonatum health tea, which is prepared from the following raw material medicines in parts by weight: 4-8 parts of yellow essence; 1-3 parts of pawpaw; 6-10 parts of momordica grosvenori; 4-8 parts of cinnamon; 3-7 parts of liquorice, and the liquorice is prepared by the processes of cleaning, drying, crushing, preparing, filling, packaging and the like. The polygonatum health tea provided by the invention is reasonable in composition, plays a role in the synergism of medicines for tonifying liver and kidney, enables blood to run smoothly, effectively overcomes liver deficiency and kidney deficiency, regulates the functions of the organism in an all-round way, improves the resistance of the organism to diseases, and achieves the purposes of body building and body strengthening.
The invention provides a preparation method of a selenium-rich tabletted candy, wherein a tabletted selenium raw material is selenoprotein instead of plant selenium, researches prove that organic selenium is lower in toxicity than inorganic selenium, the inorganic selenium can cause poisoning after being taken for a long time, and the plant selenium can also cause poisoning if being taken for a long time. Although selenium in yeast selenium is edible, the absorption effect by the human body is not ideal. Therefore, during material selection, selenoprotein is selected, and the selenoprotein has the characteristics of good absorptivity and no side effect after long-time taking.
Disclosure of Invention
The invention aims to provide a preparation method of a selenium-rich tabletted candy, and simultaneously discloses a preparation method of the tabletted candy.
The technical scheme of the invention is as follows: the preparation method of the selenium-rich tabletted candy comprises the following active ingredients in percentage by weight of the total tabletted candy:
7.5-8.4 wt% of selenium protein powder; 13-17 wt% of hawthorn; 13-17 wt% of maltodextrin; 7.42 to 8.21 weight percent of stevia powder; 7.31 to 8.05 weight percent of ginseng powder.
In the body-building tabletted candy, the active ingredients in the tabletted candy and the weight percentage of the active ingredients in the total tabletted candy are as follows:
7.5-8.4 wt% of selenium protein powder; 13-17 wt% of hawthorn; 13-17 wt% of maltodextrin; 7.42 to 8.21 weight percent of stevia powder; 7.31 to 8.05 weight percent of ginseng powder.
In the above constitution-strengthening tabletted candy, the tabletted candy consists of the following components:
7.5-8.4 wt% of selenium protein powder; 13-17 wt% of hawthorn; 13-17 wt% of maltodextrin; 7.42 to 8.21 weight percent of stevia powder; 7.31-8.05 wt% of ginseng powder; 1.13-7.05 wt% of magnesium stearate. .
The invention also discloses a preparation method of the body-building tabletting candy, which comprises the following steps:
step 1: accurately weighing the raw materials according to various indexes in the formula, and sieving maltodextrin and stevia powder with a 40-80 mesh sieve;
step 2: pulverizing ginseng and hawthorn, adding maltodextrin and stevia powder, mixing, granulating, drying at 60-65 ℃ for 2-2.5 hours, and granulating and sieving the dried raw materials for later use;
and step 3: adding the raw materials of the selenoprotein powder and the magnesium stearate into the sized raw materials, and fully and uniformly mixing the raw materials in a three-dimensional mixer for 30-45 minutes;
and 4, step 4: and (4) pouring the uniformly mixed particles into a hopper of a tablet press for tabletting, and adjusting the weight of each tablet to be 350 +/-10 mg.
The invention has the following beneficial effects:
the functional food design formula aims at the weak symptoms that most people are lack of selenium element, have weak constitution and are ill, often feel poor physical function and the like in a long-time working state, and simultaneously recover the invisible symptoms of the body. The product adopts raw materials of pure natural new resource food, and has good regulating effect on human fatigue and oxidation through a well-developed formula. Meanwhile, various body functions are regulated, the body activity is recovered, and the human body is full.
The invention adopts 4 new resource food raw materials (selenoprotein powder, hawthorn, ginseng and stevia rebaudianum powder) with reasonable design formula, and the mental condition of people can be enhanced and improved by short-term use. Can improve human body constitution, recover various functions of human body, and enhance oxidation resistance and immunity of human body after long-term consumption.
1. The selenium protein powder has the following effects:
selenium can improve human body immunity, enhance recognition ability of immune system to virus, foreign body and pathological changes in vivo, improve cell proliferation, antibody synthesis and antibody level in blood of immune system, and improve phagocytic and bactericidal ability of immune system cell, thereby improving organism immunity.
Selenium can prevent and treat cancer. Selenium is a cancer cell killing agent and forms an internal environment in vivo that inhibits cancer cell division and proliferation. After cancer operation, selenium supplement can obviously control the disease deterioration, relieve the toxic and side effects of chemotherapy and radiotherapy and help the anticancer drugs to improve the curative effect.
Selenium can prevent and treat cardiovascular and cerebrovascular diseases, supplement selenium can reduce blood viscosity, reduce blood lipid, obviously reduce cholesterol,Triglyceride and low density lipoprotein levels, while significantly increasing high density lipoprotein levels and reducing thrombosis. Because of the good protection effect on the heart, selenium is known as heart protection spirit, and food with high selenium supplement is helpful for protecting the heart.
The human liver is a selenium bank, and the selenium concentration in the liver is obviously higher than that in other tissues and organs. Selenium is a major protective factor for nutritional hepatic necrosis. The more severe the liver disease, the lower the blood selenium content. Selenium can be used for preventing and treating hepatitis and fatty liver.
Selenium can resist oxidation and delay aging. Oxidative damage in the human body is an important cause of illness and aging of the human body. Selenium can activate important substances in the body's own antioxidant system, control and relieve oxidative damage, thus preventing diseases and prolonging the life of human beings.
2. The effects and actions of hawthorn: fructus crataegi has effects of preventing and treating cardiovascular and cerebrovascular diseases, promoting blood circulation for removing blood stasis, preventing and treating cancer, and promoting digestion of fat food
3. The ginseng can enhance the immune function of the organism and prevent the cell decline caused by various reasons. And can enhance phagocytic ability of reticuloendothelial system. Can improve the lymphocyte transformation rate and the contents of r-globulin and IgM in healthy people, thereby improving the immune function of the organism.
Ginseng has sedative effects on the central nervous system, and has antagonistic effects on many stimulants and can alleviate the inhibitory effects of central depressant. Ginsenosides Rb have sedative effects on the central nervous system, while Rg may have weak excitatory effects, but have inhibitory effects when administered in excess. Ginseng can not only improve the excitation process but also enhance the inhibition process of the central nerve, so that the inhibition tends to be concentrated and the differentiation is more complete.
4. The efficacy and the effect of the stevia rebaudiana powder are as follows: stevia is a known sweet flavor material, and is a perennial herb commonly found at the junction of yerba mate and brazil in south america, the leaves of stevia contain sweet substances named "steviosin", and the refined steviosin is colorless and tasteless crystals with a sweet taste 200 times that of granulated sugar. Because of low calorie, easy dissolution in water or alcohol, and heat resistance, it is a sugar substitute product without calorie, and is a common sweet material for diet or slimming food for diabetic patients. Has effects of reducing blood sugar and relieving fatigue.
Detailed Description
The technical solution of the present invention will be described in further detail with reference to the following embodiments, but the present invention is not limited thereto.
Example 1
Step 1: accurately weighing the raw materials according to various indexes in the formula, and sieving maltodextrin and stevia powder with a 40-80 mesh sieve;
step 2: pulverizing ginseng and hawthorn, adding maltodextrin and stevia powder, mixing, granulating, drying at 60-65 ℃ for 2-2.5 hours, and granulating and sieving the dried raw materials for later use;
and step 3: adding the raw materials of the selenoprotein powder and the magnesium stearate into the sized raw materials, and fully and uniformly mixing the raw materials in a three-dimensional mixer for 30-45 minutes;
and 4, step 4: and (4) pouring the uniformly mixed particles into a hopper of a tablet press for tabletting, and adjusting the weight of each tablet to be 350 +/-10 mg.
The formula is as follows:
8 wt% of selenium protein powder; 13wt% of hawthorn; 13wt% of maltodextrin; 7.5wt% of stevia powder; ginseng powder 8 wt% example 2
Step 1: accurately weighing the raw materials according to various indexes in the formula, and sieving maltodextrin and stevia powder with a 40-80 mesh sieve;
step 2: pulverizing ginseng and hawthorn, adding maltodextrin and stevia powder, mixing, granulating, drying at 60-65 ℃ for 2-2.5 hours, and granulating and sieving the dried raw materials for later use;
and step 3: adding the raw materials of the selenoprotein powder and the magnesium stearate into the sized raw materials, and fully and uniformly mixing the raw materials in a three-dimensional mixer for 30-45 minutes;
and 4, step 4: and (4) pouring the uniformly mixed particles into a hopper of a tablet press for tabletting, and adjusting the weight of each tablet to be 350 +/-10 mg.
The formula is as follows:
7.5wt% of selenium protein powder; 15 wt% of hawthorn; 15 wt% of maltodextrin; 8.0 wt% of stevia powder; ginseng powder 7.8 wt% Performance test
1. Technical requirements
1.1 requirements of raw and auxiliary materials
The application range and the limited amount of the food additive meet the requirements of GB2760-2007 hygienic standards for use of food additives, and the application range and the limited amount of the food nutrition enhancer meet the requirements of GB14880-1994 hygienic standards for use of food nutrition enhancers.
1.1.1 Hawthorn fruit: it should meet the regulations of pharmacopoeia of the people's republic of China (2020 edition).
1.1.2 stevia rebaudiana powder: the food additive stevioside which meets the national standard of GB 8270-.
1.1.3 Ginseng (artificially planted) powder: the regulation of "the Ministry of health of the people's republic of China, No. 17 in 2012" should be met.
1.1.4 selenium protein powder: the selenium protein food nutrition enhancer meets the national food safety standard GB 1903.28-2018.
1.1.5 maltodextrin powder: should meet the requirements of pharmacopoeia of the people's republic of China (2020 edition)
1.2 sensory indices
The requirements of table 1 should be met.
TABLE 1 sensory requirements
1.3 physical and chemical indexes
Should comply with the specifications of table 2.
TABLE 2 physical and chemical indexes
1.4 Net content and negative bias
The regulation of No. 75 of State quality supervision inspection and quarantine Bureau of State quality supervision inspection and quarantine of 'quantitative package commodity measurement supervision and management method' should be met.
1.5 microbiological index
Should comply with the specifications of table 3.
TABLE 3 microbiological indicators
The product is taken by 1000 people, the using time of the product is 1 month, 2-3 tablets are taken per person every day, and 90% of people have obvious improvement on vital essence and energy and improve the immunity.
The above description is only exemplary of the present invention, and any modification, equivalent replacement, and improvement made within the spirit and scope of the present invention should be included in the protection scope of the present invention.
Claims (4)
1. The preparation method of the selenium-rich tabletted candy is characterized in that the active ingredients in the tabletted candy and the weight percentage of the active ingredients in the total tabletted candy are as follows:
7.5-8.4 wt% of selenium protein powder; 13-17 wt% of hawthorn; 13-17 wt% of maltodextrin; 7.42 to 8.21 weight percent of stevia powder; 7.31 to 8.05 weight percent of ginseng powder.
2. The method for preparing the selenium-rich tabletted candy according to claim 1, wherein the active ingredients in the tabletted candy and the weight percentage of the active ingredients in the total tabletted candy are as follows:
7.5-8.4 wt% of selenium protein powder; 13-17 wt% of hawthorn; 13-17 wt% of maltodextrin; 7.42 to 8.21 weight percent of stevia powder; 7.31 to 8.05 weight percent of ginseng powder.
3. The body-building tabletted confectionery product according to claim 1, wherein the tabletted confectionery product consists of:
7.5-8.4 wt% of selenium protein powder; 13-17 wt% of hawthorn; 13-17 wt% of maltodextrin; 7.42 to 8.21 weight percent of stevia powder; 7.31-8.05 wt% of ginseng powder; 1.13-7.05 wt% of magnesium stearate.
4. A method of making a body-building tabletted candy as claimed in claim 3, comprising the steps of:
step 1: accurately weighing the raw materials according to various indexes in the formula, and sieving maltodextrin and stevia powder with a 40-80 mesh sieve;
step 2: pulverizing ginseng and hawthorn, adding maltodextrin and stevia powder, mixing, granulating, drying at 60-65 ℃ for 2-2.5 hours, and granulating and sieving the dried raw materials for later use;
and step 3: adding the raw materials of the selenoprotein powder and the magnesium stearate into the sized raw materials, and fully and uniformly mixing the raw materials in a three-dimensional mixer for 30-45 minutes;
and 4, step 4: and (4) pouring the uniformly mixed particles into a hopper of a tablet press for tabletting, and adjusting the weight of each tablet to be 350 +/-10 mg.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011554331.1A CN112544767A (en) | 2020-12-24 | 2020-12-24 | Preparation method of selenium-rich tabletted candy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011554331.1A CN112544767A (en) | 2020-12-24 | 2020-12-24 | Preparation method of selenium-rich tabletted candy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112544767A true CN112544767A (en) | 2021-03-26 |
Family
ID=75033785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011554331.1A Withdrawn CN112544767A (en) | 2020-12-24 | 2020-12-24 | Preparation method of selenium-rich tabletted candy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112544767A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113317384A (en) * | 2021-06-30 | 2021-08-31 | 元古湖北生物科技有限公司 | Preparation process of selenium-rich ferment tablet candy |
| CN116210909A (en) * | 2022-12-09 | 2023-06-06 | 上海壹块硒健康科技有限公司 | Selenium supplementing ginseng plant selenium tablet for enhancing immunity |
-
2020
- 2020-12-24 CN CN202011554331.1A patent/CN112544767A/en not_active Withdrawn
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113317384A (en) * | 2021-06-30 | 2021-08-31 | 元古湖北生物科技有限公司 | Preparation process of selenium-rich ferment tablet candy |
| CN116210909A (en) * | 2022-12-09 | 2023-06-06 | 上海壹块硒健康科技有限公司 | Selenium supplementing ginseng plant selenium tablet for enhancing immunity |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100645385B1 (en) | Composition for anti-obesity | |
| CN107259571A (en) | One kind is for canteen thing and preparation method thereof | |
| CN110447902B (en) | Composition with weight-losing effect | |
| KR100448260B1 (en) | Processing Methods of Health Food for the Control of Body Weight | |
| CN109619566A (en) | A kind of nutraceutical for alleviating asthenopia | |
| Yampolsky et al. | Apricot (lat. Prunus armeniaca Lin.) | |
| CN112544767A (en) | Preparation method of selenium-rich tabletted candy | |
| KR101578070B1 (en) | Health supplementing food for enhancing hair restoration, alleviating and improving hair loss, adjusting blood sugar, alleviating and improving gastrointestinal disorders | |
| CN106176953A (en) | A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja, Fructus Momordicae and Folium Mori | |
| KR20040095949A (en) | Composition comprising herb with usage to prevent obeseness | |
| JP2021508433A (en) | Carob fruit composition and its preparation method and application | |
| CN102090637A (en) | Collagen-containing compound nutritious powder | |
| CN108783292A (en) | Seabuckthorn fruit peel digested tankage compound nutritional meal replacement powder rich in antioxidants and preparation method thereof | |
| KR100237168B1 (en) | Obesity-controlling health food | |
| CN105101817B (en) | Edible composition and preparation method thereof and the food comprising said composition | |
| KR100503208B1 (en) | Diet-food composition | |
| KR20190102493A (en) | A pill for functional food comprising Protaetia brevitarsis seulensis and manufacturing method therof | |
| KR20080033717A (en) | Health assistance food composition using honey and crude drugs and the making method | |
| KR100293890B1 (en) | Food composition for control of body weight and blood sugar prepared by using Dong-A Green Juice and its residue | |
| CN105815738A (en) | Product assisting in lowering blood glucose and preparation method thereof | |
| KR20170086198A (en) | Manufacturing method of diet solid tea including fermentation herb remedy and dietary fiber and the solid tea produced thereby | |
| HS et al. | Nutraceutical and medicinal values of minor fruits in Western Ghats of South India | |
| CN101731470A (en) | Drug combination for pet health and preparation method thereof | |
| KR20080107883A (en) | Composition for immune enhancement comprising the extract of see cucumber, medicinal stuff of samultang and pueraria thunbergiana benth as an active ingredient | |
| KR100450055B1 (en) | Food composition for improving physical constitution containing seeds of bean plants as main components, and food produced therefrom |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20210326 |
|
| WW01 | Invention patent application withdrawn after publication |